ANESHIA NUNLEY: Open Payments
NPI 1184388142 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 73 payments from 14 companies in 2025. Trend: 2023 $1,755 · 2024 $68 · 2025 $1,644
Food & beverage: $1,524Education: $119
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $356 |
| Neurocrine BioSciences, Inc. | 12 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $252 |
| ABBVIE INC. | 12 | $221 |
| E.R. Squibb & Sons, L.L.C. | 2 | $153 |
| Alkermes, Inc. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, UZEDY, COBENFY, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across IN — which companies pay providers there.
